Salvage Brachytherapy and Hyperthermia for Recurrent H&N-tumours

The aim of the present trial is to assess the prospective results of protocol-based interstitial pulsed-dose-rate (PDR) brachytherapy with interstitial hyperthermia (iHT) in a group of selected patients where salvage surgery with clear resection margins was not possible.

Trial Details

NCT ID
NCT03238378
Phase
NA
Sponsor
University of Erlangen-Nürnberg Medical School
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • Brachytherapy
  • Hyperthermia
Locations (sample)
  • Erlangen, Germany|49.59099,11.00783

Key Eligibility Criteria

  • Histologically confirmed recurrent carcinoma of the head and neck region
  • Stage rcT1-3
  • Tumor anatomy and location suitable for brachytherapy techniques.
  • cN0/pN0 or rpN+ \& R0 with \<3 pos. LND \& without invasion of capsula.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →